Outcome of Chinese patients with hepatitis B at 96 weeks after functional cure with IFN versus combination regimens.
Calvin Qian PanMing-Hui LiWei YiLu ZhangYao LuHong-Xiao HaoGang WanWei-Hua CaoXing-Yue WangChong-Ping RanGe ShenShu-Ling WuMin ChangYuan-Jiao GaoYao XiePublished in: Liver international : official journal of the International Association for the Study of the Liver (2021)
NUC-IFN and IFN therapies are equally effective in achieving sustained functional cure and fibrosis regression. (ClinicalTrials.gov, Number NCT02336399).